SI
KALA icon

Sofinnova Investments’s KALA BIO KALA Stock Holding History

Sofinnova Investments’s Portfolio KALA Stock Details KALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-203
Closed -$5.33M – 77
2020
Q2 		$5.33M Sell
203
-243
-54% -$6.88M 0.34% 56
2020
Q1 		$9.8M Buy
446
+180
+68% +$2.88M 0.91% 24
2019
Q4 		$2.45M Buy
266
+75
+39% +$724K 0.18% 52
2019
Q3 		$1.82M Buy
191
+72
+61% +$876K 0.16% 59
2019
Q2 		$1.9M Sell
119
-19
-14% -$315K 0.17% 60
2019
Q1 		$2.86M Sell
138
-40
-22% -$711K 0.28% 52
2018
Q4 		$2.18M Buy
178
+140
+368% +$2.43M 0.27% 50
2018
Q3 		$944K Sell
38
-83
-69% -$2.53M 0.08% 59
2018
Q2 		$4.17M Buy
121
+113
+1,413% +$4.34M 0.47% 38
2018
Q1 		$323K Buy
+8
New +$304K 0.06% 41

Other funds holding KALA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sofinnova Investments's KALA Position: Q3 2020 in Review

Sofinnova Investments sold out of KALA BIO (KALA) in Q3 2020, closing a stake of 203 shares — an estimated $5.33M sold.

Sofinnova Investments first reported a position in KALA in Q1 2018 and held it in 10 quarters. The position peaked at $9.8M in Q1 2020. 105 funds tracked by Wall St. Rank hold KALA as of Q3 2020.

  • Sofinnova Investments reported no remaining KALA BIO position as of Q3 2020 after selling out during the quarter.
  • Sofinnova Investments sold 203 KALA BIO shares in Q3 2020, an estimated $5.33M.
  • Sofinnova Investments first reported a position in KALA BIO in Q1 2018 and held it in 10 quarters.
  • Sofinnova Investments's KALA BIO position peaked at $9.8M in Q1 2020.
  • 105 funds tracked by Wall St. Rank held KALA BIO as of Q3 2020.

Based on Sofinnova Investments's 13F filing for Q3 2020, filed 13 Nov 2020.